TQCAX
Price
$19.61
Change
+$0.11 (+0.56%)
Updated
Jul 3 closing price
Net Assets
2.39B
VIVAX
Price
$70.13
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

TQCAX vs VIVAX

Header iconTQCAX vs VIVAX Comparison
Open Charts TQCAX vs VIVAXBanner chart's image
Touchstone Dividend Equity A
Price$19.61
Change+$0.11 (+0.56%)
VolumeN/A
Net Assets2.39B
Vanguard Value Index I
Price$70.13
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
TQCAX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
TQCAX vs. VIVAX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TQCAX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. TQCAX (2.4B). VIVAX pays higher dividends than TQCAX: VIVAX (2.06) vs TQCAX (1.49). TQCAX was incepted earlier than VIVAX: TQCAX (27 years) vs VIVAX (33 years). TQCAX (1.01) is less costly to investors than VIVAX (0.17). TQCAX is a more actively managed with annual turnover of: 37.00 vs. VIVAX (9.00). TQCAX has a lower initial minimum investment than VIVAX: TQCAX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 12.04 vs. TQCAX (10.46). VIVAX return over 5 years is better than : 80.14 vs. TQCAX (49.76).
TQCAXVIVAXTQCAX / VIVAX
Total Expense Ratio0.990.17582%
Annual Report Gross Expense Ratio1.010.17594%
Fund Existence27 years33 years-
Gain YTD9.7546.209157%
Front Load5%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets2.4B189B1%
Annual Yield % from dividends1.492.0672%
Returns for 1 year10.4612.0487%
Returns for 3 years28.7135.1682%
Returns for 5 years49.7680.1462%
Returns for 10 years44.10115.7438%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NFBK12.220.19
+1.58%
Northfield Bancorp
TWST38.170.49
+1.30%
Twist Bioscience Corp
FIVE131.39N/A
N/A
Five Below
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.